New York City, NY -- (SBWIRE) -- 08/26/2013 -- StockMarketIntel.com issues a special report on the following stocks: Bond Laboratories Inc (OTCMKTS:BNLB), BFC Financial Corporation (OTCMKTS:BFCF), LifeApps Digital Media Inc (OTCMKTS:LFAP), Brainstorm Cell Therapeutics Inc (OTCBB:BCLI)
Bond Laboratories Inc (OTCMKTS:BNLB) gained 2.86%, trading on 128,600 shares, to end the trade at $0.180. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.08 and was moved to the maximum level of $0.29. The stock changed hands in a range of $0.17 to $0.18, bringing its market capitalization to about $14 million. Bond Laboratories, Inc., through its subsidiaries, provides nutritional supplements for health conscious consumers in the United States. It manufactures and distributes a range of nutritional supplements to support healthy living.
Why Should Investors Buy BNLB After The Recent Gain? Just Go Here and Find Out
BFC Financial Corporation (OTCMKTS:BFCF) declined -1.26%, to complete the trading session at $2.36, with a total volume of 9,300 shares. The stock, on average, trades on a volume of 45,442 shares. In the past 52 weeks, the share price has not declined below $0.65 and above $2.86. It floated in a range of $2.36 to $2.39 during the last trading session, with a beta value of 2.44. Its market capitalization now moved to about $196.49 million. BFC Financial Corporation is a private equity and venture capital firm specializing in investments and acquisitions of middle market companies. The firm also invests in mergers and acquisition, add-on acquisitions, divestiture, taking public companies private and private companies public, leveraged buyout, partnership, recapitalization, and restructuring. It typically does not invest in industries or companies whose ultimate returns are event driven.
Why Should Investors Buy BFCF After the Recent Fall? Just Go Here and Find Out
LifeApps Digital Media Inc (OTCMKTS:LFAP) recorded a fall of -0.86% and was in a range of $0.07-$0.07 before closing at $0.0695. The share price hit its 52-week low of $0.03 and $0.48 was the best price. The stock completed the day with a total volume of 307,411 shares, versus an average volume of 783,928 shares. Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, notes in a recent article that through LifeApps Digital Media, Inc. (LFAP)'s apps available for download on mobile devices, sport and health enthusiasts can enjoy high-end guidance and content from experts on their mobile devices at a time of their choosing.
Will LFAP Get Buyers Even After The Recent Rally? Find Out Here
Brainstorm Cell Therapeutics Inc (OTCBB:BCLI) declined -4.62%, bringing its market capitalization around $32.78 million. The total number of shares that changed hands during the session was 115,201 shares, as compared to average trading volume of 536,948 shares. The share price, after opening at $0.19, made a high of $0.19 and hovered above $0.19 to end the day at $0.186. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in developing adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Parkinson?s disease, and multiple sclerosis. It holds rights to develop and commercialize its NurOwn technology through a worldwide licensing agreement with Ramot, the technology transfer company of the Tel Aviv University.
Will BCLI Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)